Loading...
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with a 5-year mortality rate of ~50%. The development of immunotherapies has improved the survival of patients with HNSCC, but, the long-term prognosis of patients with recurrent or metastatic HNSCC remains poor. HNSCC...
Na minha lista:
Main Authors: | , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Frontiers Media S.A.
2019-10-01
|
Serier: | Frontiers in Oncology |
Fag: | |
Online adgang: | https://www.frontiersin.org/article/10.3389/fonc.2019.01084/full |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|